An analysis of the TCGA’s KRAS mutant lung adenocarcinoma cohort defined a 4-gene signature of mutant tumors (overexpressing FOXRED2, TOP1, PEX3, and ABL2). Here, KRAS is linked to lung adenocarcinoma.